On 27 Aug 2021, $Chembio Diagnostics(CEMI)$ announced its launch of commercial distribution of an FDA Emergency Use Authorized, patent pending, rapid point-of-care COVID-19 antigen test for use in decentralized and traditional testing settings. Product inventory is on-hand and immediately available for shipment to Chembio customers across the United States with Institutions buying in with over 1 Million Shares reported purchased on Aug 30 2021.

This is Bullish! 📈🚀⚠️

$Atossa Genetics(ATOS)$$Bionano Genomics(BNGO)$$Quest Diagnostics(DGX)$$Theratechnologies Inc.(THTX)$